Abstract
Early-onset sepsis remains a common and serious problem for neonates, especially preterm infants. Group B streptococcus (GBS) is the most common etiologic agent, while Escherichia coli is the most common cause of mortality. Current efforts toward maternal intrapartum antimicrobial prophylaxis have significantly reduced the rates of GBS disease but have been associated with increased rates of Gram-negative infections, especially among very-low-birth-weight infants. The diagnosis of neonatal sepsis is based on a combination of clinical presentation; the use of nonspecific markers, including C-reactive protein and procalcitonin (where available); blood cultures; and the use of molecular methods, including PCR.…
Citation impact
972
total citations
- FWCI
- 54.12
- Percentile
- 100%
- References
- 322
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Procalcitonin
- Neonatal sepsis
- Medicine
- Ampicillin
- Sepsis
- Meningitis
- Immunology
- Streptococcus agalactiae
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.